Navigation Links
CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Decrease Pancreatic Cancer Tumor Blood Flow and Reduce Blood Vessel Density
Date:6/23/2011

BARCELONA, Spain, June 23, 2011 /PRNewswire/ -- CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today presented pre-clinical research results at the European Society for Medical Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer in Barcelona, Spain demonstrating that novel FAK inhibitors targeting the binding site of vascular endothelial growth factor receptor 3 (VEGFR-3) decrease pancreatic cancer tumor blood flow and reduce blood vessel density in vivo.  The research was conducted by CureFAKtor scientists at the Roswell Park Cancer Institute in Buffalo, New York.

In a poster presentation, CureFAKtor Senior Scientist Dr. Elena Kurenova reported the antiangiogenic effect of the Company's lead small molecule compound, CFAK-C4, in pancreatic cancer tumors. Contrast-enhanced magnetic resonance imaging (MRI) revealed significant reduction in tumor vascular volume and permeability in CFAK-C4-treated pancreatic tumors in vivo.  MRI-based changes in tumor vascularity were seen at both the first and second week after therapy.

CureFAKtor scientists analyzed the blood vessel density in a subcutaneous mouse pancreatic tumor model in two CFAK-C4 treated groups and compared vessel density to control group tumors treated with phosphate-buffered saline (PBS). One group was treated for 35 days with treatment starting the day after cell injection.  The second treatment group started when tumors reached a volume of 100 cubic millimeters (mm). Tumors from both groups demonstrated statistically significant reduction of blood vessels per square mm equaling blood vessel density.

A CureFAKtor study reported earlier this year pinpointed the site of interaction of VEGFR-3 and FAK to create small molecule drugs capable of disrupting signaling and causing death of pancreatic cancer cells.  
'/>"/>

SOURCE CureFAKtor Pharmaceuticals, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Targeted to Protein-Protein Binding Sites Inhibit Pancreatic Cancer Cells Growth
2. CureFAKtor Pharmaceuticals Receives Orphan Drug Designation for Its Lead Compound CFAK-C4 for the Treatment of Pancreatic Cancer
3. MAP Pharmaceuticals to Present Data on LEVADEX® at the 15th Congress of the International Headache Society
4. Radient Pharmaceuticals Corporation Joins OTCQX
5. Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50
6. Cempra Pharmaceuticals to Present at the 2011 Wells Fargo Healthcare Conference
7. Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6
8. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Voluntarily Recalls One Lot of RISPERDAL® Tablets and One Lot of Risperidone Tablets
9. Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference
10. Access Pharmaceuticals Receives Letter of Acceptance For MuGard Filing From SFDA of China
11. Cubist Pharmaceuticals Applauds Congressman Gingrey for Introducing Legislation to Help Fight Superbug Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- Research and Markets  has announced the addition ... End-user & by Lead Type - Global Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 The global diagnostic ... namely, holter monitor, resting, and stress type diagnostic ECG ... in 2013 and is poised to grow at a ...
(Date:7/23/2014)... DALLAS , July 23, 2014 ... LLC ("Plaintiff") filed suit in the 116 ... Dallas, Texas , against RegenLab USA, ... Current and Prospective Business Relationships through false ... interference; and, Business Disparagement through libel, ...
(Date:7/23/2014)... DUBLIN , July 23, 2014 ... addition of the "Global Electrophysiology Ablation Catheters ... http://photos.prnewswire.com/prnh/20130307/600769 ... to remove or destroy faulty electrical pathways from ... rhythms (also known as cardiac arrhythmias). Cardiac arrhythmias ...
Breaking Medicine Technology:Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3
... that a new market research report is available in ... Device Market Outlook to 2015 ... manufacturers are experiencing profit margin pressures due to large ... contract prices for the device supplies, and some devices ...
... Reportlinker.com announces that a new market research ... The 2011 Clinical Chemistry Market: US, ... During the next decade, ... The changes will be caused by convergence of ...
Cached Medicine Technology:Reportlinker Adds The Drug Delivery Device Market Outlook to 2015 2Reportlinker Adds The Drug Delivery Device Market Outlook to 2015 3Reportlinker Adds The 2011 Clinical Chemistry Market: US, Europe, Japan 2
(Date:7/23/2014)... Texas Physical Therapy Specialists (TexPTS) is proud to ... Liberty Hill, Parmer, Balcones, and Georgetown clinics have received ... Certified Specialist (OCS) or Sports Certified Specialist ... Tony Lauretta, PT, DPT, OCS, Jason Brown, PT, DPT, ... DPT, OCS, and Mary Grimberg, PT, DPT, OCS received ...
(Date:7/23/2014)... the likelihood of forming false memories, according to research ... the Association for Psychological Science. , In a study ... University of California, Irvine and colleagues, sleep-deprived people who ... read false information about the photos were more likely ... than were those who got a full night,s sleep. ...
(Date:7/23/2014)... CarePoint Health is proud to announce ... Jersey to receive the da Vinci® Xi™ Surgical System, ... da Vinci series. This 4th generation robotic platform is ... innovation. The intuitive da Vinci Xi has broad capabilities ... minimally invasive and complex surgical procedures. The acquisition of ...
(Date:7/23/2014)... The North American market was valued at $985.4 million ... CAGR of 10.79%, to reach $1,801.1 million by 2018. Organobromines ... North American Bromine Market report defines and segments the bromine ... Browse through the TOC of the North American Bromine Market ... This also provides a glimpse of the segmentation in the ...
(Date:7/23/2014)... Recently, Agebc.com has launched its new ... is announcing a promotion of wedding dresses. According to ... at the end of this month. , The beautiful ... like A-line, mermaid, ball-gown, empire, and more. Agebc.com is ... special-occasion dresses for women, and the company is devoted ...
Breaking Medicine News(10 mins):Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 3Health News:Sleep deprivation may increase susceptibility to false memories 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 2Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 3Health News:CarePoint Health is First in New Jersey to Receive Newest Surgical Robot Platform 4Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Bromine Market is Expected to Reach $1801.1 million in 2018 - New Report by MicroMarket Monitor 4Health News:Agebc.com Launched Its New Collection of Wedding Dresses 2
... Bird, a molecular geneticist at the University of Edinburgh, Scotland, ... of a protein called Uqcrc1 in the brains of mouse ... which are the powerhouses of the cells to work overtime. ... mitochondrial gene has been linked to Rett Syndrome. The co-author ...
... that the male survivors of childhood sexual abuse ... understood// many health care practitioners as well as ... male and female childhood sexual survivors usually exhibit ... encounters with health care professionals, there are gender ...
... that New Orleans seems to be going throuogh a ... intensity rarely seen in the US. ,Suicide ... struck, 10 months ago. To make matters worse the ... the police department to deal with the large number ...
... University and the Celiac Sprue Research Foundation have claimed ... celiac sprue// that is an inherited inflammatory disorder of ... around the world. The two research studies that have ... Biology have opened the way for clinical testing with ...
... Cadbury Ireland had on the 23rd June recalled almost ... move because there are fears// that those bars may ... the company has said that there were minute traces ... levels that stipulated by the scientific standards for any ...
... to use a protein that has been originally isolated from ... genetically// modified technology. ,The parent company, Unilever, have ... ice creams that are of low-calorie, and low fat. They ... newer versions of their best selling products like the Cornetto, ...
Cached Medicine News:Health News:Researchers Have Linked Rett Syndrome to Mitochondrial Gene 2Health News:Researchers Have Linked Rett Syndrome to Mitochondrial Gene 3Health News:Sexually Abused Males Found Struggling In heir relations with Healthcare Providers 2Health News:Scientists Discover Non-dietary Therapy For Celiac Diseases 2Health News:Wall's To Develop Low-fat Ice-cream Using Fish Blood 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: